文献速递口腔修复与种植

牙-种植体联合支持与纯种植体支持的双冠固位覆盖义齿的生存与成功:长达11年的前瞻性研究

Survival and success of tooth-implant-supported and solely implant-supported double-crown-retained overdentures: A prospective study over a period of up to 11 years.
PubMed 文献 · Clin Oral Implants Res · 2021-10-29

两组5年累积生存率分别为96.2%和97.7%,5年累积成功率分别为88.2%和81.9%,差异无统计学意义。上颌DCRD发生主要并发症的风险显著高于下颌(HR=4.87,p=.04)。

要点

  • 牙-种植体联合支持与纯种植体支持DCRD的5年生存率和成功率均较高且无显著差异。
  • 上颌DCRD发生主要并发症的风险是下颌的4.87倍(p=.04)。
  • 轻微并发症常见,需要大量后续维护。

核心结论

  • 牙-种植体联合支持与纯种植体支持的DCRD均是推荐的治疗选择,平均随访4.2年生存率和成功率均高。
  • 上颌DCRD发生主要并发症的风险显著高于下颌DCRD。

研究设计与样本

  • 前瞻性研究,2002年至2015年在海德堡大学医院口腔修复科连续纳入患者。
  • 采用Kaplan-Meier曲线评估生存与成功,混合效应Cox回归分析影响因素。

主要发现

  • 纯种植体支持组5年累积生存率为96.2%,牙-种植体联合支持组为97.7%。
  • 纯种植体支持组5年累积成功率为88.2%,牙-种植体联合支持组为81.9%,两组间无显著差异。
  • 上颌DCRD发生主要并发症的风险高于下颌(风险比4.87,p=.04)。
  • 轻微并发症常见,需要大量后续维护。

临床怎么用

  • 牙-种植体联合支持与纯种植体支持的DCRD均可作为全牙弓修复的推荐方案。
  • 上颌DCRD患者应加强随访,警惕主要并发症风险较高。
  • 应预期轻微并发症常见并安排充分的维护支持。

局限性

  • 作者指出研究设计存在局限性。
  • 平均随访时间仅为4.2年,而研究周期最长可达11年。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the long-term performance, over a period of up to 11 years, of tooth-implant-supported and solely implant-supported double-crown-retained overdentures (DCRDs) for complete restoration of the jaw. MATERIALS AND METHODS: Between 2002 and 2015, patients were consecutively enrolled in the study at Heidelberg University Hospital's Department of Prosthodontics. Scheduled and unscheduled visits were both documented on standardized forms. Kaplan-Meier curves were used to evaluate survival and success of the DCRDs. Mixed effects Cox regression was used to identify the potential effects of age, sex, jaw, location of implants, and the number of abutment teeth on the success of the DCRDs. RESULTS: One hundred and thirty-nine DCRDs were placed in 126 participants (mean age: 65.6 ± 9.1 years; 76 [60.3%] men). The mean follow-up period was 4.2 years. Fifty-three (38%) DCRDs were solely implant-supported (213 implants) and 86 (62%) were tooth-implant-supported (239 teeth and 199 implants). Cumulative five-year survival was 96.2% in the implant-supported group and 97.7% in the tooth-implant-supported group. Simultaneous consideration of failures and severe complications revealed cumulative five-year success of 88.2% for implant-supported DCRDs and 81.9% for tooth-implant-supported DCRDs, with no significant difference between the two types of restoration. Cox regression analysis revealed a greater risk of major complications (hazard ratio: 4.87, p = .04) for maxillary DCRDs than for mandibular DCRDs. CONCLUSIONS: Although the study design has limitations, the results show that tooth-implant-supported and solely implant-supported DCRDs are both recommendable treatment options. After a mean follow-up of 4.2 years, survival and success were high. However, minor complications were common and required much aftercare. CLINICAL TRIAL REGISTRATION: This study started in 2005 and was approved by the local review board of the University of Heidelberg. In 2005, clinical trial registration was not yet common. For this reason, the study was not registered.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Klotz AL, Fobbe H, Rammelsberg P, et al. Survival and success of tooth-implant-supported and solely implant-supported double-crown-retained overdentures: A prospective study over a period of up to 11 years. Clin Oral Implants Res. 2021. PMID: 34543479. doi:10.1111/clr.13842

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。